HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Stephen R Bloom Selected Research

Hyperinsulinism (Hyperinsulinemia)

5/2005Fasting and postprandial hyperghrelinemia in Prader-Willi syndrome is partially explained by hypoinsulinemia, and is not due to peptide YY3-36 deficiency or seen in hypothalamic obesity due to craniopharyngioma.
4/2004Elevated fasting plasma ghrelin in prader-willi syndrome adults is not solely explained by their reduced visceral adiposity and insulin resistance.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Stephen R Bloom Research Topics

Disease

76Obesity
06/2024 - 02/2002
32Weight Loss (Weight Reduction)
01/2024 - 08/2005
28Body Weight (Weight, Body)
11/2022 - 02/2002
23Type 2 Diabetes Mellitus (MODY)
10/2021 - 01/2005
11Overweight
01/2024 - 08/2005
8Neoplasms (Cancer)
02/2015 - 06/2004
7Insulin Resistance
11/2015 - 04/2004
7AIDS-Related Complex (ARC)
01/2014 - 06/2004
6Nausea
01/2018 - 08/2006
6Infertility (Sterility)
06/2016 - 11/2009
6Anorexia
11/2008 - 10/2003
5Hyperphagia (Overeating)
04/2014 - 06/2002
5Prader-Willi Syndrome (Syndrome, Prader-Willi)
10/2008 - 02/2002
3Prediabetic State (Prediabetes)
01/2023 - 01/2019
3Metabolic Syndrome (Dysmetabolic Syndrome X)
11/2021 - 02/2016
3Weight Gain
11/2015 - 01/2006
3Hyperglycemia
11/2014 - 08/2012
3Neoplasm Metastasis (Metastasis)
06/2012 - 11/2006
3Hypertrophy
07/2010 - 09/2007
2Liver Diseases (Liver Disease)
06/2024 - 08/2013
2Metabolic Diseases (Metabolic Disease)
11/2022 - 01/2019
2Non-alcoholic Fatty Liver Disease
01/2022 - 01/2019
2Hypoglycemia (Reactive Hypoglycemia)
01/2021 - 01/2016
2Pre-Eclampsia (Preeclampsia)
05/2015 - 11/2010
2Hypogonadism (Hypergonadotropic Hypogonadism)
01/2014 - 11/2012
2Carcinoma (Carcinomatosis)
06/2012 - 06/2010
2Morbid Obesity
10/2011 - 09/2011
2Anemia
03/2010 - 05/2009
2Malnutrition (Nutritional Deficiencies)
10/2007 - 07/2005
2Anorexia Nervosa
04/2007 - 04/2005
2Gestational Trophoblastic Disease (Trophoblastic Neoplasms, Gestational)
03/2007 - 11/2006
2Hyperinsulinism (Hyperinsulinemia)
05/2005 - 04/2004
1Type 1 Diabetes Mellitus (Autoimmune Diabetes)
01/2023
1Fatty Liver
01/2023
1Hepatocellular Carcinoma (Hepatoma)
01/2022
1Cicatrix (Scar)
11/2021
1Body Weight Changes
01/2021
1Hypersensitivity (Allergy)
01/2020

Drug/Important Bio-Agent (IBA)

45Hormones (Hormone)IBA
01/2023 - 02/2002
32Glucagon-Like Peptide 1 (GLP 1)IBA
01/2024 - 06/2004
22GhrelinIBA
01/2014 - 11/2003
17Peptide YYIBA
01/2021 - 06/2004
16Peptides (Polypeptides)IBA
01/2023 - 06/2004
16OxyntomodulinIBA
01/2019 - 12/2002
14Glucose (Dextrose)FDA LinkGeneric
01/2023 - 01/2005
13KisspeptinsIBA
06/2016 - 11/2006
12Insulin (Novolin)FDA Link
01/2019 - 02/2002
11LeptinIBA
05/2014 - 02/2002
10Glucagon (Glukagon)FDA Link
06/2024 - 08/2010
5Glucagon-Like Peptide-1 ReceptorIBA
10/2021 - 01/2018
5Pancreatic Polypeptide (Pancreatic Polypeptide (PP))IBA
02/2016 - 01/2008
4Glucagon Receptors (Glucagon Receptor)IBA
01/2024 - 01/2021
4Biomarkers (Surrogate Marker)IBA
02/2016 - 12/2011
4Appetite Depressants (Anorectics)IBA
12/2011 - 06/2004
3Amino AcidsFDA Link
06/2024 - 11/2022
3Proglucagon (Glucagon Precursors)IBA
01/2020 - 11/2014
3Peptide Hormones (Polypeptide Hormones)IBA
01/2017 - 05/2005
3Gastrointestinal Hormones (Hormones, Gastrointestinal)IBA
02/2016 - 04/2005
3Cholecystokinin (Pancreozymin)IBA
08/2010 - 12/2007
3Pro-Opiomelanocortin (Proopiomelanocortin)IBA
02/2010 - 11/2004
2Blood Glucose (Blood Sugar)IBA
01/2024 - 01/2011
2CholesterolIBA
01/2022 - 07/2005
2LigandsIBA
01/2022 - 11/2020
2Proteins (Proteins, Gene)FDA Link
11/2021 - 03/2018
2LiraglutideFDA Link
01/2021 - 01/2019
2Exenatide (Byetta)FDA Link
03/2018 - 05/2012
2InulinFDA Link
01/2017 - 11/2015
2Phosphotransferases (Kinase)IBA
01/2016 - 11/2014
2IncretinsIBA
12/2015 - 02/2002
2Messenger RNA (mRNA)IBA
01/2014 - 08/2005
2NeuropeptidesIBA
08/2013 - 05/2013
2Chromogranin AIBA
06/2012 - 05/2012
2Amphetamine (Amfetamine)FDA LinkGeneric
05/2012 - 04/2008
2Cocaine (Cocaine HCl)IBA
05/2012 - 04/2008
2Islet Amyloid PolypeptideIBA
08/2010 - 01/2008
2Glucagon-Like Peptide 2IBA
07/2010 - 07/2005
2salicylhydroxamic acid (SHAM)IBA
05/2010 - 05/2010
2IronIBA
03/2010 - 05/2009
2HepcidinsIBA
03/2010 - 05/2009
1Glucagon-Like Peptide ReceptorsIBA
01/2024
1semaglutideIBA
01/2024
1Saline SolutionIBA
01/2023
1Wiskott-Aldrich Syndrome ProteinIBA
11/2021
1Monensin (Coban)IBA
11/2021
1G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA
10/2021
1ArrestinsIBA
01/2021
1Nerve Growth Factor (NGF)IBA
01/2020
1TRPV1 receptorIBA
01/2020
1Glial Cell Line-Derived Neurotrophic Factor (GDNF)IBA
01/2020
1CannabidiolIBA
01/2020
1Nerve Growth Factors (Neurotrophins)IBA
01/2020
1Therapeutic UsesIBA
01/2020

Therapy/Procedure

35Therapeutics
01/2023 - 07/2003
16Gastric Bypass (Roux-en-Y Gastric Bypass)
01/2023 - 11/2006
13Bariatric Surgery
01/2021 - 01/2006
3Drug Therapy (Chemotherapy)
11/2021 - 03/2007
2Gastrectomy
01/2023 - 01/2019
2Vagus Nerve Stimulation
11/2018 - 01/2018
2Subcutaneous Injections
11/2009 - 01/2006
1Caloric Restriction
01/2021